Active	Status	Sponsor type	Region	Phase	Filter
4 Active 8 Inactive 12 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Auxora (zegocractin) / CalciMedica
CalciMedica_COVID: FDA Grants CalciMedica Permission to Begin Dosing CM4620-IE in Patients with Severe COVID-19 Pneumonia under a Newly Opened IND	Not yet recruiting	2	0	California	CM4620 - CalciMedica	CalciMedica	COVID-19
KOURAGE, NCT06374797: A Study of Auxora in Patients with AKI and Injurious Lung "Crosstalk"	Recruiting	2	150	US	Auxora, Placebo	CalciMedica, Inc.	Acute Kidney Injury	08/25	08/25
CARPO, NCT04681066: A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS	Completed	2	216	US, RoW	CM-4620 Injectable Emulsion or CM-4620-IE, Auxora, Placebo	CalciMedica, Inc.	Acute Pancreatitis, Systemic Inflammatory Response Syndrome	05/24	05/24
CRSPA, NCT04195347: Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase	Recruiting	1/2	42	US	CM4620, CM4620-IE	St. Jude Children's Research Hospital, CalciMedica, Inc.	Acute Pancreatitis	06/25	12/27
long acting sunitinib maleate (GB-103) / CalciMedica
No trials found